Delivery Order SPE2DR25D3404-SPE2DR26F5T9F
- Not listed
- The Defense Logistics Agency awarded a $2,739.35 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. This is a firm fixed price contract with an ultimate completion date of November 14, 2025, and represents a small-value delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract was awarded non-competitively through this existing indefinite delivery contract,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a ceiling value of $20,183.30. This competitively awarded, firm fixed-price delivery order represents a single-award transaction with an ultimate completion date of October 30, 2025. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vial, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,108.26 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of ferumoxytol, a 510 mg/17 ml vial of pharmaceutical medication, to the Defense Logistics Agency (DLA). The $1,630.03 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 3, 2024. The contract has an ultimate completion date of December 4, 2024 and was not set aside for any specific type of business. AmerisourceBergen holds a significant $999,999,999...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $13,203.17 from the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, indicating a rapid fulfillment requirement. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,966.41 delivery order is for the supply of 510 mg/17 mL vials of the drug ferumoxytol. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a firm fixed price, with a ceiling value of $8,423.11, and a completion date of October 10, 2024. This contract is not designated as a set-aside. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts and indefinite delivery contracts...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 17 mL vials of the injectable iron replacement medication ferumoxytol. The $13,498 firm fixed price contract has a period of performance through September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is a significant supplier of medical commodities to the U.S. federal government, including military treatment facilities and other healthcare providers. The...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5T9FDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Ferumoxytol 510 mg/17 mL vials valued at $3,451.18 with a firm fixed price structure. The award was made on December 1, 2025, with an ultimate completion date of December 2, 2025, and does not carry a set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The Defense Logistics Agency, operating under the Department of Defense, utilizes such contracts to maintain critical pharmaceutical inventories supporting military medical operations globally. AmerisourceBergen's role as a prime vendor under the DLA Troop Support Medical program reflects its significant capacity to deliver specialty medications, brand-name and generic drugs, and related medical commodities across multiple therapeutic domains. Ferumoxytol, an intravenous iron replacement therapy, represents the type of specialized medical product the contractor routinely supplies through this established contract vehicle to support Defense Health Agency requirements and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/30/25 |